Search Results - "Nully Brown, Peter"

Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study by Rossetti, Sára, Juul, Sidsel Jacobsen, Eriksson, Frank, Warming, Peder Emil, Glinge, Charlotte, El‐Galaly, Tarec Christoffer, Haaber Christensen, Jacob, Kamper, Peter, Nully Brown, Peter, Gislason, Gunnar Hilmar, Vestmø Maraldo, Maja, Tfelt‐Hansen, Jacob, Hutchings, Martin

“…Summary The documented treatment‐induced excess mortality in Hodgkin lymphoma (HL) has spurred important treatment changes over recent decades. This study…”
Get full text

Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma by El-Galaly, Tarec Christoffer, d'Amore, Francesco, Mylam, Karen Juul, de Nully Brown, Peter, Bøgsted, Martin, Bukh, Anne, Specht, Lena, Loft, Annika, Iyer, Victor, Hjorthaug, Karin, Nielsen, Anne Lerberg, Christiansen, Ilse, Madsen, Charlotte, Johnsen, Hans-Erik, Hutchings, Martin

“…To investigate whether bone marrow biopsy (BMB) adds useful information to [(18)F]fluorodeoxyglucose (FDG) positron emission tomography/computed tomography…”
Get full text

Social inequality in cancer survivorship: Educational differences in health‐related quality of life among 27,857 cancer survivors in Denmark by Levinsen, Anne Katrine Graudal, Kjaer, Trille Kristina, Thygesen, Lau Caspar, Maltesen, Thomas, Jakobsen, Erik, Gögenur, Ismail, Borre, Michael, Christiansen, Peer, Zachariae, Robert, Christensen, Peter, Laurberg, Søren, Nully Brown, Peter, Hölmich, Lisbet Rosenkrantz, Johansen, Christoffer, Kjær, Susanne K., Poll‐Franse, Lonneke, Saltbæk, Lena, Dalton, Susanne Oksbjerg

“…Background With a growing population of cancer survivors in Denmark, the evaluation of health‐related quality of life (HRQoL) has become increasingly…”
Get full text

Mental health among patients with non‐Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators by Øvlisen, Andreas Kiesbye, Jakobsen, Lasse Hjort, Kragholm, Kristian Hay, Nielsen, René Ernst, Nully Brown, Peter, Dahl‐Sørensen, Rasmus Bo, Frederiksen, Henrik, Mannering, Nikolaj, Josefsson, Pär Lars, Ludvigsen Al‐Mashhadi, Ahmed, Jørgensen, Judit Mészáros, Dessau‐Arp, Andriette, Clausen, Michael Roost, Pedersen, Robert Schou, Torp‐Pedersen, Christian, Severinsen, Marianne Tang, El‐Galaly, Tarec Christoffer

“…Psychological distress following cancer diagnosis may lead to mental health complications including depression and anxiety. Non‐Hodgkin lymphomas (NHLs)…”
Get full text

Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP(−like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group by Ludvigsen Al‐Mashhadi, Ahmed, Cederleuf, Henrik, Kuhr Jensen, Rasmus, Holm Nielsen, Torsten, Bjerregård Pedersen, Martin, Bech Mortensen, Thomas, Relander, Thomas, Jerkeman, Mats, Ortved Gang, Anne, Kristensen, Anne Louise, Roost Clausen, Michael, Nully Brown, Peter, Tang Severinsen, Marianne, Jakobsen, Lasse Hjort, Ellin, Fredrik, El‐Galaly, Tarec Christoffer

“…Peripheral T‐Cell Lymphomas (PTCLs) are rare, aggressive lymphomas with poor outcomes, but limited‐stage disease is infrequent and not well‐described. This…”
Get full text

Sinonasal B‐cell lymphomas: A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B‐cell lymphoma by Eriksen, Patrick R. G., Clasen‐Linde, Erik, Nully Brown, Peter de, Haunstrup, Laura, Christoffersen, Mette, Asdahl, Peter, Thomsen, Troels Møller, Harwood, Cecilie Dupont, Heegaard, Steffen, Buchwald, Christian von

“…Lymphomas of the nasal cavity and paranasal sinuses (NPS) are rare. Knowledge on sinonasal B‐cell lymphoma (SNBCL) primarily comes from case series or…”
Get full text

No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish‐Swedish population‐based observational study by Jakobsen, Lasse H., Hutchings, Martin, Nully Brown, Peter, Linderoth, Johan, Mylam, Karen J., Molin, Daniel, Johnsen, Hans E., Bøgsted, Martin, Jerkeman, Mats, El‐Galaly, Tarec C.

“…Summary The use of routine imaging for patients with classical Hodgkin lymphoma (HL) in complete remission (CR) is controversial. In a population‐based study,…”
Get full text

The Danish National Lymphoma Registry: Coverage and Data Quality by Arboe, Bente, El-Galaly, Tarec Christoffer, Clausen, Michael Roost, Munksgaard, Peter Svenssen, Stoltenberg, Danny, Nygaard, Mette Kathrine, Klausen, Tobias Wirenfeldt, Christensen, Jacob Haaber, Gørløv, Jette Sønderskov, Brown, Peter de Nully

“…The Danish National Lymphoma Register (LYFO) prospectively includes information on all lymphoma patients newly diagnosed at hematology departments in Denmark…”
Get full text

Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors by Salz, Talya, Zabor, Emily C, de Nully Brown, Peter, Dalton, Susanne Oksberg, Raghunathan, Nirupa J, Matasar, Matthew J, Steingart, Richard, Vickers, Andrew J, Svenssen Munksgaard, Peter, Oeffinger, Kevin C, Johansen, Christoffer

“…Purpose The use of anthracycline chemotherapy is associated with heart failure (HF) among survivors of non-Hodgkin lymphoma (NHL). We aimed to understand the…”
Get full text

A population‐based study of prognosis in advanced stage follicular lymphoma managed by watch and wait by El‐Galaly, Tarec Christoffer, Bilgrau, Anders E., Nully Brown, Peter, Mylam, Karen J., Ahmad, Syed A., Pedersen, Lars M., Gang, Anne O., Bentzen, Hans H., Juul, Maja B., Bergmann, Olav J., Pedersen, Robert S., Nielsen, Berit J., Johnsen, Hans E., Dybkær, Karen, Bøgsted, Martin, Hutchings, Martin

“…Summary Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular lymphoma (FL), but single‐agent rituximab is an alternative for…”
Get full text

Simplicity at the cost of predictive accuracy in diffuse large B‐cell lymphoma: a critical assessment of the R‐IPI, IPI, and NCCN‐IPI by Biccler, Jorne, Eloranta, Sandra, Nully Brown, Peter, Frederiksen, Henrik, Jerkeman, Mats, Smedby, Karin E., Bøgsted, Martin, El‐Galaly, Tarec C.

“…The international prognostic index (IPI) and similar models form the cornerstone of clinical assessment in newly diagnosed diffuse large B‐cell lymphoma…”
Get full text

Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas by Marquard, Lena, Poulsen, Christian B, Gjerdrum, Lise Mette, De Nully Brown, Peter, Christensen, Ib J, Jensen, Peter B, Sehested, Maxwell, Johansen, Preben, Ralfkiær, Elisabeth

“…Aims:  Histone deacetylase (HDAC) inhibitors are novel therapeutics in the treatment of peripheral T‐cell lymphoma, unspecified (PTCL) and diffuse large B‐cell…”
Get full text

Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL by Knudsen, Steen, Hother, Christoffer, Grønbæk, Kirsten, Jensen, Thomas, Hansen, Anker, Mazin, Wiktor, Dahlgaard, Jesper, Møller, Michael Boe, Ralfkiær, Elizabeth, Brown, Peter de Nully

“…MicroRNAs (miRNA) are a group of short noncoding RNAs that regulate gene expression at the posttranscriptional level. It has been shown that microRNAs are…”
Get full text

Sexual health and testosterone concentration in male lymphoma survivors: A systematic review by Micas Pedersen, Signe, Hersby, Ditte Stampe, Jarden, Mary, Nielsen, Torsten Holm, Gang, Anne Ortved, Poulsen, Christian Bjørn, de Nully Brown, Peter, Jørgensen, Niels, Feltoft, Claus Larsen, Pedersen, Lars Møller

“…Advancements in lymphoma treatment have increased the number of long-term survivors who may experience late effects such as impaired sexual function and…”
Get full text

The Danish National Multiple Myeloma Registry by Gimsing, Peter, Holmström, Morten O, Klausen, Tobias Wirenfelt, Andersen, Niels Frost, Gregersen, Henrik, Pedersen, Robert Schou, Plesner, Torben, Pedersen, Per Trøllund, Frederiksen, Mikael, Frølund, Ulf, Helleberg, Carsten, Vangsted, Annette, de Nully Brown, Peter, Abildgaard, Niels

“…The Danish National Multiple Myeloma Registry (DMMR) is a population-based clinical quality database established in January 2005. The primary aim of the…”
Get full text

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial by Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra, de Nully Brown, Peter, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus, Pfreundschuh, Michael

“…Six cycles of R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) are the standard treatment for aggressive B-cell non-Hodgkin…”
Get full text

Idelalisib in relapsed/refractory diffuse large B‐cell lymphoma: results from a Nordic Lymphoma Group phase II trial by Fjordén, Karin, Ekberg, Sara, Kuric, Nevzeta, Smedby, Karin E., Lagerlöf, Ingemar, Larsen, Thomas S., Jørgensen, Judit M., Nully Brown, Peter, Jerkeman, Mats

Get full text

Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors—A population‐based cohort study from Sweden and Denmark by Glimelius, Ingrid, Englund, Annika, Rostgaard, Klaus, Smedby, Karin E., Eloranta, Sandra, de Nully Brown, Peter, Johansen, Christoffer, Kamper, Peter, Ljungman, Gustaf, Hjalgrim, Lisa Lyngsie, Hjalgrim, Henrik

“…The burden of late effects among Hodgkin lymphoma (HL) survivors treated according to contemporary protocols remains poorly characterized. We used nation‐wide…”
Get full text

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma by Maurer, Matthew J., Jakobsen, Lasse H., Mwangi, Raphael, Schmitz, Norbert, Farooq, Umar, Flowers, Cristopher R., Nully Brown, Peter, Thompson, Carrie A., Frederiksen, Henrik, Cunningham, David, Jørgensen, Judit, Poeschel, Viola, Nowakowski, Grzegorz, Seymour, John F., Merli, Francesco, Haioun, Corinne, Ghesquieres, Hervé, Ziepert, Marita, Tilly, Hervé, Salles, Gilles, Shi, Qian, El‐Galaly, Tarec C., Habermann, Thomas M.

“…Disease progression after frontline therapy for Diffuse large B‐cell lymphoma (DLBCL) is a clinically significant event. Patients who experience early…”
Get full text

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group by Pfreundschuh, Michael, Prof, Kuhnt, Evelyn, MSc, Trümper, Lorenz, Prof, Österborg, Anders, Prof, Trneny, Marek, Prof, Shepherd, Lois, MD, Gill, Devinder S, MD, Walewski, Jan, MD, Pettengell, Ruth, Prof, Jaeger, Ulrich, Prof, Zinzani, Pier-Luigi, MD, Shpilberg, Ofer, Prof, Kvaloy, Stein, Prof, de Nully Brown, Peter, MD, Stahel, Rolf, MD, Milpied, Noel, Prof, López-Guillermo, Armando, MD, Poeschel, Viola, MD, Grass, Sandra, MD, Loeffler, Markus, Prof, Murawski, Niels, MD

“…Summary Background The MInT study was the first to show improved 3-year outcomes with the addition of rituximab to a CHOP (cyclophosphamide, doxorubicin,…”
Get full text